Regulations

Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access

June 25, 2024
Featuring: Lia Mix, LMFT, CPTR

In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement.

Subscribe Share

In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement.

After many years of working in community mental health and 15 years in the commercial health insurance industry (where she helped to establish coverage for autism), Mix was one of the first graduates of CIIS’s training program, and after a very distinct MDMA-assisted therapy session, she wondered: “How can I be of service?” She’s since helped to launch The Board of Psychedelic Medicines and Therapies, the American Psychedelic Practitioners Association, and Enthea, and is working every day toward a more unified and uniform psychedelic space, with healthcare frameworks, official boards and certifications, consumer protections, and a general consensus that this is our responsibility to manage – not some outside regulator’s. So how can we, as a scattered psychedelic community, come together?

She discusses:

  • Her path to psychedelics and how nobody was talking about how to bring psychedelics into healthcare
  • The need for a unified code of ethics for any practitioner of psychedelic therapy
  • The FDA, Lykos Therapeutics, and how the recent advisory committee’s recommendations on MDMA-assisted psychotherapy were largely based on fear
  • How there actually is a lot of financial possibility if we can all agree on what is absolutely essential right now

and more!

Links

Delphi-circle.com

Board of Psychedelic Medicine and Therapies

American Psychedelic Practitioners Association

Enthea.com

National Psychedelic Association

Psychedelic Medicine Association

Matthew Remski – Cultic Mechanisms and After Effects of High Demand Group Life

Psychedelicalpha.com: Exclusive: Therapists and Trialists from Lykos’ Phase 3 MDMA-Assisted Therapy Studies Push Back on ICER’s Critical Draft Report

Lykospbc.com: Lykos Therapeutics Statement on FDA Advisory Committee Meeting

MAPS Podcast: Episode 33: Matthew Baggott – Beyond Fear – MDMA and Emotion

Rocky Mountain Poison & Drug Safety

PT438 – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy, featuring: Lynn Marie Morski, MD, JD

Mymodernmet.com: Kintsugi: The Centuries-Old Art of Repairing Broken Pottery with Gold

Psychedelics and The Shadow: The Shadow Side of Psychedelia: Exploring the dark and golden shadow of psychedelia

Psychedelic Pharmacists Association

Sandor Iron Rope

Lia Mix

In this Episode

Lia Mix, LMFT, CPTR

Lia Mix is the Founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement. With a career spanning over two decades, Lia is a licensed marriage and family therapist (LMFT) and certified in Psychedelic Therapies and Research (CPTR) by the California Institute for Integral Studies. At Delphi, she provides expertise in organizational objectives related to psychedelics, conscious leadership, and project management for leading nonprofits, for-profits, foundations, and government bodies. Lia has been instrumental in establishing the core infrastructure for integrating psychedelic-assisted therapy into the U.S. healthcare system, including achieving health insurance coverage for new behavioral health treatments.

Socials: Linkedin